QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online 9 January 2007
doi: 10.1242/jcs.03350

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jcs.03350v1 120/3/447    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JCS Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gentzsch, M. Articles by Riordan, J. R. Search for Related Content PubMed PubMed Citation Articles by Gentzsch, M. Articles by Riordan, J. R. Social Bookmarking                         What's this?

Misassembled mutant F508 CFTR in the distal secretory pathway alters cellular lipid trafficking

¹ Department of Cell and Developmental Biology and Cystic Fibrosis Research Center, University of North Carolina, Chapel Hill, NC 27599, USA
² Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
³ Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Scottsdale, AZ 85259, USA
⁴ Department of Biochemistry and Biophysics and Cystic Fibrosis Research Center, University of North Carolina, Chapel Hill, NC 27599, USA

^* Author for correspondence (e-mail: gentzsch{at}med.unc.edu)

Accepted 17 November 2006

Most patients with cystic fibrosis (CF) have a single codon deletion (F508) in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) that impairs assembly of the multidomain glycoprotein. The mutant protein escapes endoplasmic reticulum (ER) quality control at low temperature, but is rapidly cleared from the distal secretory pathway and degraded in lysosomes. CF cells accumulate free cholesterol similar to Niemann-Pick disease type C cells. We show that this lipid alteration is caused by the presence of misassembled mutant CFTR proteins, including F508, in the distal secretory pathway rather than the absence of functional CFTR. By contrast, cholesterol distribution is not changed by either D572N CFTR, which does not mature even at low temperature, or G551D, which is processed normally but is inactive. On expression of the F508 mutant, cholesterol and glycosphingolipids accumulate in punctate endosomal structures and cholesterol esters are reduced, indicating a block in the translocation of cholesterol to the ER for esterification. This is overcome by Rab9 overexpression, resulting in clearance of accumulating intracellular cholesterol. Similar but less pronounced alterations in intracellular cholesterol distribution are observed on expression of a temperature-rescued mutant variant of the related ATP-binding cassette (ABC) protein multidrug resistance-associated protein 1 (MRP1). Thus, on escape from ER quality control, misassembled mutants of CFTR and MRP1 impair lipid homeostasis in endocytic compartments.

Key words: CFTR, Cholesterol, Cystic fibrosis, Glycosphingolipids, Lipid trafficking

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

Related articles in JCS:

When quality control goes awry

JCS 2007 120: 303. [Full Text]  

This article has been cited by other articles:

				Y. Guo, M. Su, M. A. McNutt, and J. Gu Expression and Distribution of Cystic Fibrosis Transmembrane Conductance Regulator in Neurons of the Human Brain J. Histochem. Cytochem., December 1, 2009; 57(12): 1113 - 1120. [Abstract] [Full Text] [PDF]

				G. Mailhot, Z. Ravid, S. Barchi, A. Moreau, R. Rabasa-Lhoret, and E. Levy CFTR knockdown stimulates lipid synthesis and transport in intestinal Caco-2/15 cells Am J Physiol Gastrointest Liver Physiol, December 1, 2009; 297(6): G1239 - G1249. [Abstract] [Full Text] [PDF]

				H. Barriere, M. Bagdany, F. Bossard, T. Okiyoneda, G. Wojewodka, D. Gruenert, D. Radzioch, and G. L. Lukacs Revisiting the Role of Cystic Fibrosis Transmembrane Conductance Regulator and Counterion Permeability in the pH Regulation of Endocytic Organelles Mol. Biol. Cell, July 1, 2009; 20(13): 3125 - 3141. [Abstract] [Full Text] [PDF]

				E. M. Bradford, M. A. Sartor, L. R. Gawenis, L. L. Clarke, and G. E. Shull Reduced NHE3-mediated Na+ absorption increases survival and decreases the incidence of intestinal obstructions in cystic fibrosis mice Am J Physiol Gastrointest Liver Physiol, April 1, 2009; 296(4): G886 - G898. [Abstract] [Full Text] [PDF]

				Z. Zhou, D. Treis, S. C. Schubert, M. Harm, J. Schatterny, S. Hirtz, J. Duerr, R. C. Boucher, and M. A. Mall Preventive but Not Late Amiloride Therapy Reduces Morbidity and Mortality of Lung Disease in {beta}ENaC-overexpressing Mice Am. J. Respir. Crit. Care Med., December 15, 2008; 178(12): 1245 - 1256. [Abstract] [Full Text] [PDF]

				M. E. Manson, D. A. Corey, N. M. White, and T. J. Kelley cAMP-mediated regulation of cholesterol accumulation in cystic fibrosis and Niemann-Pick type C cells Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L809 - L819. [Abstract] [Full Text] [PDF]

				M. Griese, M. Kappler, A. Gaggar, and D. Hartl Inhibition of airway proteases in cystic fibrosis lung disease Eur. Respir. J., September 1, 2008; 32(3): 783 - 795. [Abstract] [Full Text] [PDF]